Cost Per Response Analysis of Nivolumab Versus Everolimus...

Cost Per Response Analysis of Nivolumab Versus Everolimus in the Treatment of Patients Previously Treated with Advanced Renal Cell Carcinoma – Brazil Private Health Care System Perspective

Brust, L, Bernardino, G, Aratangy, G, Tanaka, S, Paladini, L, Borges, L, Clark, OA
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
20
Language:
english
Journal:
Value in Health
DOI:
10.1016/j.jval.2017.08.2579
Date:
October, 2017
File:
PDF, 59 KB
english, 2017
Conversion to is in progress
Conversion to is failed